MediPharm Labs Ships over CAD$10m of Cannabis Oil in December 2018
Perth, Jan 17, 2019 AEST (ABN Newswire) - MMJ Group Holdings Limited (
ASX:MMJ) (MMJJF:OTCMKTS) ("MMJ") is delighted to attach a copy of a news release by MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) (MLCPF:OTCMKTS) announcing that it had shipped over CAD$10 million of cannabis oil in December 2018.
MMJ owns approximately 4.4 million shares for a 4.3% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs. This investment currently represents approximately 17% of the market value of MMJ's investment portfolio.
MMJ's CEO Jason Conroy commented that "We are delighted by the initial sales performance by MediPharm Labs and look forward to further revenue growth and business development announcements by their management team in 2019."
To view the news release, please visit:
http://abnnewswire.net/lnk/MGPRBG4V
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
